BAT-8007

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameBAT-8007

Drug Alias NameBAT-8007

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionDNA topoisomerase I inhibitorsAnti-NECTIN4

TargetsDNA topoisomerase INectin-4

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesBio-Thera Solutions Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesBio-Thera Solutions Ltd

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A